Aim: To propose a pharmacokinetic non-linear analysis method to determine contrast medium (CM) dose for computed tomography (CT) hepatic enhancement to improve body size dependency and validate the proposed CM dose determination method through a clinical study.
Materials and methods: Enhancement data of 105 patients who underwent hepatic dynamic CT with a fixed CM dose were analysed. From the analysis results, CM doses as a function of each of four body size indices (body weight [BW], lean body weight [LBW], blood volume [BV], and body surface area [BSA]) for achieving improved body size dependency were determined (proposed method), and the body size dependencies were simulated using the enhancement data from 105 patients. The proposed method was validated with a two-arm clinical study on BW. Body size dependency was evaluated using p-value of correlation coefficient between Body size indices and enhancements (p<0.05: significant dependency) and mean absolute error (MAE).
Results: The simulation showed that significant body size dependencies not considered by the conventional method can be improved by the proposed method. MAEs of BW, LBW, and BV were also significantly reduced (p<0.05). The clinical study with BW demonstrated a similar improvement to that in the simulation result. MAE was also significantly reduced (p<0.001).
Conclusion: The proposed method demonstrated more improved BW, LBW, and BV dependence compared to the conventional method. Through the two-arm clinical study, the proposed method using BW only, without height information, is a suitable index for improving body size dependency.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Body Size Indexes for Optimizing Iodine Dose for Aortic and Hepatic Enhancement at Multidetector CT: Comparison of Total Body Weight, Lean Body Weight, and Blood VolumeH Kondo et al. Radiology 254 (1), 163-9. PMID 20019137. - Randomized Controlled TrialWhen LBW, rather than TBW or BV, is used, the iodine dose required to achieve consistent hepatic enhancement may be estimated more precisely and with reduced patient-to-p …
Body Size Indices to Determine Iodine Mass With Contrast-Enhanced Multi-Detector Computed Tomography of the Upper Abdomen: Does Body Surface Area Outperform Total Body Weight or Lean Body Weight?H Kondo et al. Eur Radiol 23 (7), 1855-61. PMID 23508277. - Randomized Controlled TrialIodine load may need to be tailored by LBW or BSA in contrast enhanced MDCT of the abdomen. BSA is a simple and feasible index for the determination of iodine dose in ind …
Hepatic Contrast Medium Enhancement at Computed Tomography and Its Correlation With Various Body Size MeasuresA Svensson et al. Acta Radiol 53 (6), 601-6. PMID 22761344.To achieve a consistent hepatic enhancement, CM dose may simply be adjusted to body weight instead of using more complicated calculated parameters based on both weight an …
The Relationship Between Drug Clearance and Body Size: Systematic Review and Meta-Analysis of the Literature Published From 2000 to 2007SC McLeay et al. Clin Pharmacokinet 51 (5), 319-30. PMID 22439649. - ReviewTo the best of our knowledge, this is the first study to have performed a meta-analysis of covariate relationships between CL and body size. Although many studies reporte …
NTP Research Report on the CLARITY-BPA Core Study: A Perinatal and Chronic Extended-Dose-Range Study of Bisphenol A in Rats [Internet]National Toxicology Program. PMID 31305969. - ReviewBisphenol A (BPA, CAS #80-05-7) is a high-production-volume industrial chemical used as a monomer for polycarbonate plastics and epoxy resins that have broad applications …